Table 1 Characteristics of patients analyzed
All patients | Mena | Womena | |
|---|---|---|---|
Characteristic | (N = 6442) | (N = 3405) | (N = 3036) |
Sex: Female [n (%)] | 3036 (47.1) | — | — |
Current age (years) [mean (SD)] | 63.2 (10.9) | 62.2 (10.8) | 64.3 (11.0) |
< 45 [n (%)] | 324 (5.0) | 186 (5.5) | 138 (4.6) |
45–64 [n (%)] | 3074 (47.7) | 1756 (51.6) | 1317 (43.4) |
65–75 [n (%)] | 2209 (34.3) | 1082 (31.8) | 1127 (37.1) |
> 75 [n (%)] | 824 (12.8) | 374 (11.0) | 450 (14.8) |
BMI (kg/m2) [mean (SD)] | 30.3 (5.2) | 29.5 (4.4) | 31.2 (5.9) |
< 25 [n (%)] | 769 (11.9) | 431 (12.7) | 338 (11.1) |
25 to <30 [n (%)] | 2672 (41.5) | 1604 (47.1) | 1068 (35.2) |
30 to <35 [n (%)] | 1979 (30.7) | 1010 (29.7) | 969 (31.9) |
35 to <40 [n (%)] | 711 (11.0) | 279 (8.2) | 431 (14.2) |
≥ 40 [n (%)] | 311 (4.8) | 81 (2.4) | 230 (7.6) |
Current or previous smoker [n (%)] | 2007 (31.2) | 1720 (50.5) | 287 (9.5) |
Waist circumference (cm) [mean (SD)]b | 101.8 (12.8) | 103.7 (12.2) | 99.5 (13.1) |
Duration of diabetes (years) [mean (SD)] | 7.4 (6.7) | 7.0 (6.3) | 7.8 (7.0) |
Patients on oral antidiabetes drugs [n (%)] | 6046 (93.9) | 3173 (93.2) | 2872 (94.6) |
HbA1c (%) [mean (SD)] | 7.4 (1.5) | 7.3 (1.5) | 7.4 (1.4) |
≤ 6.5 [n (%)] | 1911 (29.7) | 1055 (31.0) | 856 (28.2) |
> 6.5–7 [n (%)] | 939 (14.6) | 490 (14.4) | 449 (14.8) |
> 7–8 [n (%)] | 1664 (25.8) | 870 (25.6) | 794 (26.2) |
> 8–9 [n (%)] | 997 (15.5) | 493 (14.5) | 504 (16.6) |
> 9 [n (%)] | 767 (11.9) | 406 (11.9) | 360 (11.9) |
FBG (mmol/L) [mean (SD)] | 9.0 (2.9) | 9.0 (2.9) | 9.1 (2.9) |
Total cholesterol (mmol/L) [mean (SD)] | 5.2 (1.1) | 5.1 (1.2) | 5.3 (1.1) |
HDL-C (mmol/L) [mean (SD)] | 1.3 (0.4) | 1.2 (0.4) | 1.3 (0.4) |
LDL-C (mmol/L) [mean (SD)] | 3.2 (0.9) | 3.1 (0.9) | 3.2 (0.9) |
Triglycerides (mmol/L) [mean (SD)] | 1.9 (1.3) | 1.9 (1.5) | 1.8 (1.1) |
SBP (mmHg) [mean (SD)] | 139.1 (17.7) | 138.0 (17.1) | 140.4 (18.3) |
DBP (mmHg) [mean (SD)] | 79.7 (10.3) | 79.5 (10.3) | 80.0 (10.2) |